$48.30
-0.94 (-1.91%)
Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)
CAPS Rating:
A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.
RSS Headlines
Fool UK